[go: up one dir, main page]

ECSP13012799A - USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS - Google Patents

USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS

Info

Publication number
ECSP13012799A
ECSP13012799A ECSP13012799A ECSP13012799A EC SP13012799 A ECSP13012799 A EC SP13012799A EC SP13012799 A ECSP13012799 A EC SP13012799A EC SP13012799 A ECSP13012799 A EC SP13012799A
Authority
EC
Ecuador
Prior art keywords
lactoferrins
diseases
conditions
improve resistance
nutritional compositions
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Anja Wittke
Cecilia Munoz
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,833 external-priority patent/US20120171164A1/en
Priority claimed from US12/980,825 external-priority patent/US20120172288A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of ECSP13012799A publication Critical patent/ECSP13012799A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente revelación se refiere al uso de composiciones nutricionales incluyendo lactoferrinas de una fuente no humana para mejorar la resistencia a enfermedades o condiciones. El método incluye la administración a un humano de una composición nutricional que comprende una fuente de grasa o lípidos, una fuente de proteína y lactoferrinas producidas por una fuente no humana.The present disclosure relates to the use of nutritional compositions including lactoferrins from a non-human source to improve resistance to diseases or conditions. The method includes the administration to a human of a nutritional composition comprising a source of fat or lipids, a source of protein and lactoferrins produced by a non-human source.

ECSP13012799 2010-12-29 2013-07-29 USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS ECSP13012799A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/980,833 US20120171164A1 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
US12/980,825 US20120172288A1 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions

Publications (1)

Publication Number Publication Date
ECSP13012799A true ECSP13012799A (en) 2013-10-31

Family

ID=45507878

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012799 ECSP13012799A (en) 2010-12-29 2013-07-29 USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS

Country Status (13)

Country Link
EP (1) EP2658389A1 (en)
CN (2) CN107668721A (en)
BR (1) BR112013015458A2 (en)
CA (1) CA2823018A1 (en)
EC (1) ECSP13012799A (en)
HK (1) HK1250608A1 (en)
MX (1) MX2013005943A (en)
PE (1) PE20141826A1 (en)
PH (1) PH12013500917A1 (en)
RU (1) RU2013134133A (en)
SG (1) SG190780A1 (en)
TW (1) TW201306760A (en)
WO (1) WO2012091945A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20122152A1 (en) 2012-12-17 2014-06-18 Progine Farmaceutici S R L COMPOSITION FOR TOPICAL USE.
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20160015068A1 (en) * 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
EP2992894A1 (en) 2014-09-05 2016-03-09 Progine Farmaceutici Srl Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections
IT201600128713A1 (en) * 2016-12-20 2018-06-20 Frima Res Srls COMPOSITION IN THE TREATMENT OF INFLAMMATORY ANEMIA OR FROM FLOGOSIS FROM CHRONIC DISEASE
WO2022091023A1 (en) * 2020-11-02 2022-05-05 Apharm Srl Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system
CN115886073A (en) * 2022-04-01 2023-04-04 北京三元食品股份有限公司 Fermented milk

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
CA2101274C (en) 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (en) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ Separation of lactoferrin from milk
EP1480524B1 (en) 2002-03-07 2013-04-17 Upfront Chromatography A/S A process of isolating lactoferrin
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Use of bovine lactoferrin in the preparation of medicines for inhibiting bacterial growth
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
BRPI0616456A2 (en) * 2005-09-28 2011-06-21 Ventria Bioscience formulation to prevent or treat enteric disorders, diarrhea or inflammatory bowel disease or to promote beneficial intestinal flora growth, oral rehydration solution and oral rehydration formulation in the form of a powder or liquid concentrate
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
CN101130079A (en) * 2007-07-19 2008-02-27 浙江省中医药研究院 Application of lactoferrin in preparation of medicine for preventing and treating diseases caused by human rotavirus
MY160434A (en) * 2007-11-26 2017-03-15 Nestec Sa Age-tailored nutrition system for infants
ITRM20080163A1 (en) * 2008-03-26 2009-09-27 Maurizio Acri USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS
CN102724886A (en) * 2009-10-29 2012-10-10 雀巢产品技术援助有限公司 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
PH12013500917A1 (en) 2024-06-03
RU2013134133A (en) 2015-02-10
BR112013015458A2 (en) 2016-08-09
EP2658389A1 (en) 2013-11-06
PE20141826A1 (en) 2014-12-17
MX2013005943A (en) 2013-10-01
HK1250608A1 (en) 2019-01-11
CN107668721A (en) 2018-02-09
WO2012091945A1 (en) 2012-07-05
TW201306760A (en) 2013-02-16
CA2823018A1 (en) 2012-07-05
CN103429092A (en) 2013-12-04
SG190780A1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
ECSP13012799A (en) USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS
MX2015007933A (en) OLIGOSACARIDS OF HUMAN MILK TO IMPROVE STRESS SYMPTOMS.
CR20110466A (en) ANTI-ERBB-3 / ANTI-C-MET ANTI-ERBB ANTIBODIES
ECSP17043318A (en) COMPOSITION CONTAINING CHITIN AND DIGERIBLE PROTEINS
BR112014024903A2 (en) bispecific antibodies to human tweak and human il17 and their uses
BR112015006402A2 (en) set of at least one vegetable protein and at least one dairy protein
ECSP13012795A (en) USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO STIMULATE IMMUNE CELLS
PE20151806A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING MAGNESIUM THREONATE AND USE OF THE SAME
AR097144A1 (en) SOLID FOOD COMPOSITION FOR RUMINANTS AND METHOD TO PREPARE IT
BR112014003640A2 (en) weight loss methods and ketogenic compositions
BR112015030268A2 (en) pharmaceutical composition, container, kit, and method for preparing a composition
BR112015024040A2 (en) allergenic preparation
AR095334A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH STIMULATING PROPERTIES OF ADIPONECTINE AND METHOD TO PROMOTE A HEALTHY BODY WEIGHT
AR100951A1 (en) FOOD COMPOSITION FOR RUMINANTS AND PREPARATION METHOD
AR097143A1 (en) MINERAL FOOD COMPOSITION FOR LAMER FOR RUMINANTS AND METHOD TO PREPARE IT
ECSP13012798A (en) METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION
AR098034A1 (en) FOOD COMPOSITION FOR RUMINANT ANIMALS CONTAINING CARBOHYDRATES AND PREPARATION METHOD
CL2014001385A1 (en) Method and composition to increase the proportion of dietary ingredients that are resistant to degradation by rumen microorganisms
BR112013027474A2 (en) compositions that improve palatability
BR112015024064A2 (en) rodenticidal soft bait composition and method of preparing the composition
BR112013021391A2 (en) chewing gum flavor premixes, methods for making flavor premixes and chewing gum compositions thereof
AR098035A1 (en) FOOD COMPOSITION FOR RUMINANT ANIMALS CONTAINING PROTEINS AND PREPARATION METHOD
MX384303B (en) COMPOSITIONS AND METHODS FOR IMPROVED MUSCLE METABOLISM.
BR112016028973A2 (en) sweet taste receptor antagonist compositions
MY179829A (en) Anti-regurgitation nutritional composition